Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Refined C-Reactive Protein Cutoffs Help Assess Sepsis Risk in Preterm Babies

By LabMedica International staff writers
Posted on 02 Dec 2025

Early-onset sepsis (EOS) is a dangerous bloodstream infection that appears in the first three days of life, yet its early symptoms resemble many benign newborn conditions. More...

To support urgent treatment decisions, clinicians often turn to C-reactive protein (CRP). While CRP is widely used and has a strong negative predictive value, its optimal cutoffs during the first 72 hours of life have been unclear. A multicenter retrospective study now offers a clearer solution by defining time- and gestation-specific CRP thresholds that help identify which newborns—particularly preterm infants—are most likely to have EOS.

In the study conducted at The Chinese University of Hong Kong (Hong Kong SAR), researchers reviewed electronic health records across all public hospitals to evaluate CRP’s diagnostic performance in more than 100,000 newborns over 11 years. The investigators found that CRP rises naturally after birth in healthy babies, peaking around 24 to 32 hours, and this rise is markedly higher in term infants.

Because of this physiological spike, elevated CRP values early in life may not signal infection in term newborns and can lead to unnecessary antibiotic exposure. In contrast, CRP proved far more reliable in preterm infants. A cutoff above 8.0 mg/L after four hours of life identified infection with strong diagnostic performance among babies born before 34 weeks. For early-onset meningitis, a CRP level greater than 12.0 mg/L showed high specificity and strong negative predictive value, helping rule out disease.

The findings emphasize that CRP should not be interpreted using a universal cutoff for all newborns. Instead, clinicians must account for gestational age, timing of sampling, and the expected physiological rise after birth. Used selectively—especially in preterm infants—CRP can provide meaningful support in EOS screening and help guide when to pursue further testing for meningitis.

“Ours is the first population-based study to evaluate how well CRP testing can identify EOS in newborns, highlighting the fluctuations of CRP levels in a real-world setting,” said Prof. Hugh Simon Lam, who led the research team. “Although CRP isn’t a perfect biomarker for EOS detection, it can still help assess infection risk in preterm babies and guide clinicians on whether further testing for meningitis is needed.”

Related Link
The Chinese University of Hong Kong


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.